» Articles » PMID: 39035354

Implications of LncRNAs in -associated Gastrointestinal Cancers: Underlying Mechanisms and Future Perspectives

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

() is a harmful bacterium that is difficult to conveniently diagnose and effectively eradicate. Chronic infection increases the risk of gastrointestinal diseases, even cancers. Despite the known findings, more underlying mechanisms are to be deeply explored to facilitate the development of novel prevention and treatment strategies of infection. Long noncoding RNAs (lncRNAs) are RNAs with more than 200 nucleotides. They may be implicated in cell proliferation, inflammation and many other signaling pathways of gastrointestinal cancer progression. The dynamic expression of lncRNAs indicates their potential to be diagnostic or prognostic biomarkers. In this paper, we comprehensively summarize the processes of infection and the treatment methods, review the known findings of lncRNA classification and functional mechanisms, elucidate the roles of lncRNAs in -related gastrointestinal cancer, and discuss the clinical perspectives of lncRNAs.

References
1.
Huarte M, Guttman M, Feldser D, Garber M, Koziol M, Kenzelmann-Broz D . A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010; 142(3):409-19. PMC: 2956184. DOI: 10.1016/j.cell.2010.06.040. View

2.
Cho J, Prashar A, Jones N, Moss S . Helicobacter pylori Infection. Gastroenterol Clin North Am. 2021; 50(2):261-282. DOI: 10.1016/j.gtc.2021.02.001. View

3.
Malfertheiner P, Camargo M, El-Omar E, Liou J, Peek R, Schulz C . Helicobacter pylori infection. Nat Rev Dis Primers. 2023; 9(1):19. PMC: 11558793. DOI: 10.1038/s41572-023-00431-8. View

4.
Sterbenc A, Jarc E, Poljak M, Homan M . virulence genes. World J Gastroenterol. 2019; 25(33):4870-4884. PMC: 6737321. DOI: 10.3748/wjg.v25.i33.4870. View

5.
He Y, Zhang M, Wu X, Sun X, Xu T, He Q . High MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival time. PLoS One. 2013; 8(12):e79769. PMC: 3855613. DOI: 10.1371/journal.pone.0079769. View